Growth in individuals with Saul-Wilson syndrome.
Adolescent
Adult
Body Height
/ genetics
Child
Child, Preschool
Clubfoot
/ diagnostic imaging
Dwarfism
/ diagnostic imaging
Facies
Female
Fetal Growth Retardation
/ diagnostic imaging
Humans
Infant
Infant, Newborn
Male
Microcephaly
/ diagnostic imaging
Mutation
/ genetics
Osteochondrodysplasias
/ diagnostic imaging
Vesicular Transport Proteins
/ genetics
Young Adult
COG4
G516R
Saul-Wilson syndrome
primordial dwarfism
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
24
04
2020
accepted:
04
06
2020
pubmed:
12
7
2020
medline:
9
6
2021
entrez:
12
7
2020
Statut:
ppublish
Résumé
Saul-Wilson syndrome (SWS) is a rare autosomal recessive disorder characterized by microcephalic primordial dwarfism, spondyloepimetaphyseal dysplasia, characteristic facial findings, clubfoot, brachydactyly, bilateral cataracts, and hearing loss. Recently, recurrent mutations in COG4, encoding a component of the Conserved Oligomeric Golgi (COG) complex, were identified. We created detailed growth curves for stature, weight, and head circumference, as well as weight-for-length and weight velocity charts for younger children, derived from hundreds of data points obtained by retrospective chart review from 14 individuals with molecularly-confirmed SWS. In addition, we performed statistical comparisons of height-for-age model fits before and after initiation of growth hormone supplementation, and found that this therapy does not appear to influence height in individuals with SWS. We hope that these charts will represent valuable tools for clinicians, both in assessing whether SWS seems an appropriate diagnosis, as well as to monitor growth of affected individuals. In particular, we hope that our detailed growth characterization will reduce morbidity resulting from unnecessarily aggressive nutritional interventions by well-intentioned physicians trying to promote weight gain, an unrealistic goal in this genetically-determined cause of primordial dwarfism.
Identifiants
pubmed: 32652690
doi: 10.1002/ajmg.a.61754
pmc: PMC9016779
mid: NIHMS1794796
doi:
Substances chimiques
COG4 protein, human
0
Vesicular Transport Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2110-2116Subventions
Organisme : Intramural NIH HHS
ID : ZIA HG200407
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00007/5
Pays : United Kingdom
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Am J Med Genet. 1990 Mar;35(3):388-93
pubmed: 2309787
Am J Hum Genet. 2018 Oct 4;103(4):553-567
pubmed: 30290151
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Am J Med Genet A. 2012 Nov;158A(11):2719-25
pubmed: 22821869
Pediatrics. 2010 Oct;126(4):e836-42
pubmed: 20855391
Trends Cell Biol. 2006 Feb;16(2):113-20
pubmed: 16406524
Comput Stat Data Anal. 2010 Dec 1;54(12):3131-3143
pubmed: 20729976
Am J Med Genet. 1994 Jul 1;51(3):194-9
pubmed: 8074143
Pediatrics. 1987 May;79(5):706-12
pubmed: 3575026